Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
NOT FOR HUMAN CONSUMPTION - NOT FDA APPROVED
Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP 1) receptors. It is being extensively investigated for its effects on appetite regulation, glucose metabolism, insulin sensitivity and energy balance.
By activating both incretin pathways, Tirzepatide has become an important focus of research into obesity, metabolic disorders and body weight regulation.
Research
Tirzepatide has been evaluated in multiple large scale human clinical trials, where research has demonstrated significant effects on body weight reduction, glycemic control and cardiometabolic health in adults with obesity and type 2 diabetes.
Ongoing studies continue to investigate its potential applications in additional metabolic conditions, including cardiovascular disease, chronic kidney disease and metabolic dysfunction associated steatotic liver disease (MASLD), providing an expanding understanding of its biological effects.
Bacteriostatic water is included.
NOT FOR HUMAN CONSUMPTION - NOT FDA APPROVED
Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose dependent insulinotropic polypeptide (GIP) and glucagon like peptide 1 (GLP 1) receptors. It is being extensively investigated for its effects on appetite regulation, glucose metabolism, insulin sensitivity and energy balance.
By activating both incretin pathways, Tirzepatide has become an important focus of research into obesity, metabolic disorders and body weight regulation.
Research
Tirzepatide has been evaluated in multiple large scale human clinical trials, where research has demonstrated significant effects on body weight reduction, glycemic control and cardiometabolic health in adults with obesity and type 2 diabetes.
Ongoing studies continue to investigate its potential applications in additional metabolic conditions, including cardiovascular disease, chronic kidney disease and metabolic dysfunction associated steatotic liver disease (MASLD), providing an expanding understanding of its biological effects.
Bacteriostatic water is included.